Navigation Links
Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
Date:2/7/2008

DALLAS, Feb. 7 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that Jeffrey B. Davis, Chairman and CEO of Access, is scheduled to deliver a presentation about the company at the 10th Annual BIO CEO & Investor Conference on February 13, 2008 at 12:30 pm Eastern Time. The conference will take place February 11-13, 2008 in New York City at the Waldorf Astoria Hotel.

The presentation will be webcast live via the Company's web site at http://www.accesspharma.com.

About Access:

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; Prodrax(R), a non-toxic prodrug which is activated in the hypoxic zones of solid tumors to kill cancer cells; Alchemix, a chemotherapeutic agent that combines multiple modes of action to overcome drug resistance. Access is also developing Phenylbutyrate ("PB"), an HDAC inhibitor and differentiating agent currently a Phase 2 clinical candidate. For additional information on Access Pharmaceuticals, please visit our website at http://www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio
2. Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access
3. Access Pharmaceuticals Announces $2.7 Million New Equity
4. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
5. Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
6. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
7. Access Pharmaceuticals Announces $19.5 Million Recapitalization
8. Access Genetics Announces New Executive Appointments
9. Pharmasset Accesses up to $30 Million of Working Capital
10. Monitorforhire.com Adds Mobile Phone Capability Further Speeding Access to Experienced Monitors
11. CorVel Corporation Medical Provider Network Adds New Providers to Increase Savings and Improve Access to Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq:...m.D., president and chief executive officer, will ...re Conference. , ,Presentation details are as fol...rence,Date: Tuesday, December 1, 2009,Time: ... Palace Hotel, New York, NY,Webcast: <a href=,h...
(Date:11/24/2009)...wire-FirstCall/ -- IES (Nasdaq: IESC ), a leading...s systems and services for the commercial, industr...its commercial business group has been awarded a c...ectrical systems for the Level 4 bio-safety lab (B...l Research Institute of Infectious Diseases (USAMR...
(Date:11/24/2009)...nvestment bank KTA Capital,s client Neuren Pharmac...nvertible note private placement with a U.S. insti...ged by KTA Capital as Neuren,s exclusive placement... York (PRWEB) November 23, 2009 -- The independent...KTA Capital") has announced that its client N...
(Date:11/24/2009)...o, Nov. 24 Dow AgroScien...ets of Hyland Seeds, a division of Thompsons Limit...eds will further expand Dow AgroSciences, current ...oduction of SmartStax(TM) in 2010 and Dow Ag...corn in 2012. The transactional close is expected ...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...New Opportunities, NEW BRUNSWICK, N.J., Nov. 15 ...nizational changes to sharpen its,focus on opportu...nd in the,growing intersections of health care. Th...wth organization and two new business operating gr...h for Johnson & Johnson by building,on the unique ...
...nd Best Inventor Pitch for,U-Md. Bioscience Day, ...nd professor who invented a new technology enablin... plastics won the attention of a group of,venture ... at Bioscience,Day 2007, held Nov. 13., Sponsored...alization,the College of Chemical and Life Science...
...c. (Nasdaq: HALO ), a biopharmaceutical company d...e extracellular matrix, today announced,that its B...viously adopted,on May 4, 2006 (the "Rights Agreem... for triggering the stockholder rights granted pur...nt (15%) ownership interest to a,twenty percent (2...
Other Biology Technology:Johnson & Johnson Announces Changes to Accelerate Growth 2Johnson & Johnson Announces Changes to Accelerate Growth 3Pure Plastics Pitch Proves Perfect 2Pure Plastics Pitch Proves Perfect 3Halozyme Therapeutics Amends Stockholder Rights Plan 2
(Date:11/25/2009)..., police officers and ambulance workers faced a te...omplex. They battled to save people from the colla... fires and evacuated as many people as they could ...ple. And making their jobs even harder was the pro...d their relatives jammed mobile networks with call...
(Date:11/25/2009)...y be just as vital to your health as what you eat,...gical Studies. Their experiments in mice revealed ...enes in the liverthe body,s metabolic clearinghous...e body,s circadian clock as conventional wisdom ha...y of a large number of genes completely independen...
(Date:11/24/2009)... flabby arteries from collapsing have been true li...no longer needed -- once the arteries are strength... had no choice but to leave them in place. , Pro...tment of Biomedical Engineering has developed a ne... where they,re needed, then dissolves. , "Our ne...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2GlaxoSmithKline Statement Confirming alli Safety 55350 1Experimental Treatment Could Fight Muscular Dystrophy 55348 1Experimental Treatment Could Fight Muscular Dystrophy 55348 2Hormone therapy for prostate cancer patients with heart conditions linked to increased death risk 55346 1Hormone therapy for prostate cancer patients with heart conditions linked to increased death risk 55346 2
...cement officials may some day have a new ally - a ...r for virtually all of the major threat agents tha...tem is under development by a team of Lawrence Liv...ngineers, and has already been tested in laborator...e, the team has conceptually shown that they can a...
...tion of crude oil made from pig manure, chemists a...gy (NIST) are certain about a number of things. , ...ure," says NIST chemist Tom Bruno. , But a job,s ...tailed chemical analysis revealing what processing...fuel for vehicles or heating. Mass production of t...
...rself an empty-nester with a well-established rese...d time to pursue an artistic activity that paralle...l beaded sculptures in the shapes of viruses that ...long with artworks by two other scientists will be...ancement of Science Gallery starting 16 June. , ...
Other Biology News:Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances 2Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances 3NIST chemists get scoop on crude 'oil' from pig manure 2Beaded viruses and geology-inspired paintings show the art in science 2Beaded viruses and geology-inspired paintings show the art in science 3
Site-directed DNA Mutagenesis Service from Yorkshire Bioscience Ltd
Toxoplasma IgM ELISA Kit, Single from Bio-Quant Inc.
Gel Loading Dye (Bromophenol Blue, Xylene Cyanol/Glycerol) from Mo Bio Laboratories, Inc.
CMV IgG ELISA Kit, Single from Bio-Quant Inc.
Biology Products: